Uniparental Disomy: A Thorough UK Guide to imprinting, mechanisms and clinical implications

Uniparental disomy is a rare genetic situation where a person inherits both copies of a chromosome from one parent and none from the other. While a healthy person typically has one set of chromosomes from each parent, uniparental disomy can disrupt normal development when imprinted genes come into play or when it reveals recessive mutations. This guide explains what uniparental disomy means, how it occurs, the conditions it can cause, how it is diagnosed, and what families might expect in terms of counselling and management in the United Kingdom and beyond.

What is Uniparental Disomy and why does it matter?

Uniparental disomy, often abbreviated as UPD, is a genetic phenomenon in which an individual possesses two homologous chromosomes (or parts of chromosomes) from a single parent, paired with none from the other parent for the same chromosome. The consequences of UPD hinge on two factors: the gene content of the affected chromosome and the presence of genomic imprinting, a process whereby genes are expressed differently depending on whether they are inherited from the mother or the father.

In many cases UPD does not cause noticeable health issues. However, when the two copies come from a parent in which certain genes are silenced through imprinting, the balance of gene expression can be disrupted. In other chromosomes, UPD may uncover recessive diseases by making the child homozygous for a genetic variant carried by one parent. The clinical picture therefore depends on the chromosome involved and the specific genetic or imprinting mechanisms at play.

Uniparental Disomy: types, mechanisms and terminology

Isodisomy versus heterodisomy

UPD is commonly classified into two main types, each with distinct genetic implications:

• Isodisomy – two identical copies of a single chromosome from one parent. This form increases the risk of recessive diseases if the parent carries a recessive variant, because the child receives the same allele twice.
• Heterodisomy – two different homologues from the same parent. This occurs when a parent has both copies of a chromosome and passes different variants to the offspring. Heterodisomy may not automatically reveal a recessive condition but can still disrupt imprinting on the affected chromosome.

Segmental UPD can occur when only a portion of a chromosome is duplicated from one parent, with the remainder inherited normally. Segmental UPD often arises as part of a chromosomal abnormality rescue process and can be more difficult to detect than whole-chromosome UPD.

How uniparental disomy arises: trisomy rescue, monosomy rescue and more

Uniparental disomy most commonly originates during early embryonic development through a fault-tolerant rescue process after an abnormal chromosomal event. The principal mechanisms include:

• Trisomy rescue – an initial trisomy (three copies of a chromosome) is corrected by losing one copy during cell division. If the two remaining copies come from the same parent, UPD results. This is the most frequent route to UPD for many chromosomes involved in imprinting disorders.
• Monosomy rescue – a monosomy (one copy of a chromosome) is compensated by duplicating the existing chromosome, potentially leading to UPD if the duplicated copy comes from the same parent.
• Gamete complementation – a rare situation where one gamete contributes two chromosomes and the other contributes none, producing UPD in the zygote.

These rescue events are spontaneous and occur early in development. In many cases UPD is confined to a mosaic subset of cells, which can complicate the clinical picture and testing.

Segmental UPD: a partial imprinting puzzle

When UPD affects only a segment of a chromosome, or when only a small portion of a chromosome shows uniparental inheritance, the clinical outcomes depend on which genes lie within that segment. Segmental UPD can contribute to imprinting disorders or reveal recessive variants located within the duplicated area, even if the rest of the chromosome is inherited normally.

Imprinting, chromosomes and the key clinical syndromes associated with UPD

Imprinting refers to the parent-of-origin-specific expression of certain genes. In UPD, the balance of maternal and paternal imprinting can be disrupted, leading to characteristic syndromes. The most well-established associations involve specific chromosomes where imprinting effects are strong, especially chromosomes 7, 11, 14, 15 and sometimes 20.

Angelman and Prader-Willi syndromes: a classic UPD duo on chromosome 15

Two archetypal imprinting disorders illustrate the impact of UPD on health:

• Prader-Willi syndrome (PWS) can arise when an individual has two copies of chromosome 15 from the father (paternal UPD15) and no maternal copy. This disrupts expression of paternal genes in the 15q11-13 region, a critical zone for normal satiety, muscle tone and growth.
• Angelman syndrome (AS) occurs when there are two maternal copies of chromosome 15 (maternal UPD15) with no paternal copy, leading to loss of paternal UBE3A gene expression in the brain.

These conditions highlight why UPD matters clinically: the parent of origin of the chromosome determines which genes are active or silenced, shaping the phenotype in distinct ways.

Kagami-Ogata syndrome and Temple/Beckwith-like imprinting on chromosome 14

Other imprinting disorders tied to UPD involve chromosome 14. In particular:

• Paternal UPD14 is associated with Kagami-Ogata syndrome, characterised by distinctive facial features, growth retardation, abdominal wall defects and other anomalies.
• Maternal UPD14 can lead to Temple syndrome, which features low birth weight, feeding difficulties and postnatal growth issues, with a spectrum of associated traits.

Growth and feeding disorders: Silver-Russell and beyond

Maternal UPD7 is a well-recognised cause of Silver-Russell syndrome (SRS), a growth restriction disorder with distinctive facial features and relative body asymmetry. While UPD7 is the classic cause, other genetic mechanisms can produce a similar clinical picture. In practice, when SRS is suspected, testing for UPD7 is part of a broader diagnostic workup that includes methylation analyses and imaging as needed.

Diagnosing uniparental disomy: when, how and what tests are used

Diagnosis of UPD typically occurs due to a clinical suspicion triggered by growth abnormalities, developmental delay, distinctive physical features or a family history suggestive of imprinting disorders. In the modern clinical setting, a combination of genetic and epigenetic tests is used:

Methylation testing: the imprinting key

Methylation-specific tests are designed to assess the methylation status of imprinting control regions. These tests can reveal the absence or abnormal pattern of methylation associated with UPD for certain chromosomes, particularly chromosome 15 in Angelman and Prader-Willi syndromes. Methylation patterns often provide a rapid, non-invasive indication of imprinting imbalance and point clinicians towards UPD as a cause.

SNP microarray and genome-wide testing: mapping UPD

Single nucleotide polymorphism (SNP) microarrays are powerful tools in UPD detection. They help identify long contiguous stretches of homozygosity that may indicate isodisomy, or detect uniparental disomy by revealing unusual parental-origin patterns. In cases of isodisomy, large regions of homozygosity without a normal heterozygosity pattern across a chromosome can be a telltale sign.

Targeted testing for specific imprinting disorders

For suspected UPD involving chromosome 15 or 14, targeted methylation and genetic testing are often pursued first. In suspected UPD7 (Silver-Russell syndrome), a combination of methylation testing and clinical criteria guides evaluation. In some cases, parental testing is performed to determine the origin of the UPD and to understand recurrence risk for future pregnancies.

Prenatal diagnosis and testing options

UPD can be detected before birth in pregnancies where there is a high risk due to prior family history or abnormal prenatal findings. Prenatal testing may include chorionic villus sampling (CVS) or amniocentesis with subsequent methylation testing or SNP array analysis. When UPD is identified prenatally, genetic counselling becomes crucial to discuss potential outcomes, recurrence risks and options for pregnancy management.

What does UPD mean for recurrence risk and family planning?

For most cases of uniparental disomy, recurrence risk in future pregnancies is low. UPD typically arises as a sporadic event during meiosis or early embryonic development and is not usually inherited in a straightforward Mendelian fashion. However, there are nuanced scenarios where recurrence risk may be higher:

• If UPD is a consequence of a balanced translocation or other rearrangement in a parent, recurrence risk may be elevated and specific genetic counselling is advised.
• In very rare cases, a parent might carry a mosaic or germline alteration that predisposes to nondisjunction or trisomy rescue events, slightly increasing recurrence risk compared with the general population.
• Segmental UPD impacting crucial regions may require evaluation for subtle, familial variants in the parent that could be reintroduced in future conceptions.

Genetic counselling plays a central role after a UPD diagnosis. Counselors explain the mechanism behind the UPD, discuss the imprinting effects relevant to the chromosome involved, outline potential health implications, and provide information about laboratory testing for future pregnancies. In the UK, families can access genetic services through NHS services, with options for private genetic counselling if desired.

What to expect clinically: manifestations and management of UPD-related conditions

Clinical features by chromosome and imprinting impact

The phenotype of UPD depends on which chromosome is involved and whether maternal or paternal copies are present. In imprinting disorders, characteristic features include growth deviations, neurodevelopmental differences, feeding and breathing challenges, and distinctive facial or body features. Because UPD can be mosaic, not all tissues may show the same imprinting pattern, which can complicate recognition and diagnosis.

Management and multidisciplinary care

Management of UPD-related conditions is typically multidisciplinary. It may involve:

• Pediatric genetics and developmental paediatrics monitoring
• Early intervention services including speech, occupational and physical therapy
• Endocrinology input for growth and metabolic considerations
• Dietary guidance and gastroenterology support if feeding difficulties are present
• Educational planning and support for learning and behaviour

Several imprinting disorders have well-established care pathways, while others may require individualised care plans. Families benefit from connecting with patient associations and clinicians who specialise in imprinting disorders to access the latest guidance and resources.

Laboratory and research advances: where UPD stands today

The field of UPD and imprinting disorders is rapidly evolving. Advances in genomic technologies, epigenetics, and bioinformatics are enhancing our ability to detect UPD with greater precision and to understand its consequences. In research settings, large-scale genome-wide analyses help unravel rare UPD cases, enabling better genotype–phenotype correlations. Clinically, the integration of methylation testing with array-based platforms provides a robust framework for diagnosing imprinting disorders linked to UPD.

Emerging therapies and future directions

There is ongoing interest in whether epigenetic therapies or targeted interventions could modulate imprinting effects in a subset of UPD-related conditions. While such approaches are not standard of care today, research continues to explore potential strategies to mitigate developmental and metabolic consequences in imprinting disorders. The focus remains on supportive care, timely diagnosis, and informed family planning.

Practical guidance for families and carers

If UPD is diagnosed or suspected, here are practical steps to navigate the process effectively:

• Seek genetic counselling early to understand the UPD mechanism, potential health implications and recurrence risks for future pregnancies.
• Ask about coordinated care with a multidisciplinary team suited to the chromosome involved and the clinical features observed.
• Maintain records of all medical evaluations, test results and developmental assessments for easy reference during follow-up appointments.
• Connect with patient organisations and support groups that focus on imprinting disorders to share experiences and obtain reliable information.
• Discuss prenatal diagnostic options if planning another pregnancy, including the possibility of preimplantation genetic testing where appropriate.

Key takeaways: understanding uniparental disomy in plain language

To summarise, uniparental disomy is a rare genetic event in which a child inherits both copies of a chromosome from one parent and none from the other. The clinical impact depends on imprinting processes and the specific chromosomes involved. The most well-known UPD-related conditions include Prader-Willi syndrome and Angelman syndrome on chromosome 15, Silver-Russell syndrome associated with chromosome 7, and imprinting disorders involving chromosome 14. Diagnosis relies on a combination of methylation studies and SNP microarray analyses, often guided by clinical features and family history. When UPD is identified, genetic counselling helps families understand the condition, its implications for existing children and the relatively low but real recurrence risk for future pregnancies. As research advances, our understanding of UPD and imprinting disorders continues to grow, offering hope for improved diagnostics and future therapies.

Frequently asked questions about uniparental disomy

Is uniparental disomy common?

No. Uniparental disomy is a rare genetic event. It occurs in a small fraction of pregnancies and in a portion of individuals with imprinting disorders. Ongoing clinical testing helps identify UPD in affected patients or in families seeking answers after abnormal pregnancy or developmental concerns.

Can UPD be inherited?

Most UPD cases are de novo, arising spontaneously during conception and early embryonic development. They are not usually inherited in a simple pattern. However, specific parental chromosomal rearrangements or mosaicism can influence recurrence risk, underscoring the value of genetic counselling.

What are the main clinical outcomes of UPD?

Outcomes vary by chromosome and the imprinting pattern involved. Some individuals with UPD may be asymptomatic or have mild features, while others may have recognisable imprinting disorders or, in cases of isodisomy, recessive conditions. Early recognition supports timely intervention and tailored care plans.

Where can I access UPD testing and counselling in the UK?

Most UPD testing and counselling pathways are available through the National Health Service (NHS) genetic services. General practitioners and consultants can refer families to clinical genetics departments for comprehensive evaluation, appropriate testing, and ongoing management plans. Private clinics are also an option for those seeking additional opinions, though NHS services are typically comprehensive and well integrated with multidisciplinary teams.

Uniparental disomy represents a fascinating intersection of genetics, development and clinical care. By understanding the mechanisms, the imprinting landscape and the practical steps for diagnosis and management, families, clinicians and researchers can work together to illuminate this rare condition and support those who are affected.